Category Archives: Business of Medicine

iWonder Pro Enterprise Offers Device Surveillance and Management for Hospitals for iPhone, iPad and iPod touch

Schools and businesses that issue iPad, iPhone or other iOS devices to their students or staff now have a way to control where those devices can go on the internet, monitor where they have been, and lock them down to only appropriate sites.Life Record Technologies, creators of the consumer based iWonder Pro application to control and monitor children on iPhone, iPad and iPod touch devices, releases the first enterprise level surveillance and control software for schools, hospitals and businesses.

“With the release of iBooks 2 featuring text book support by Apple Inc. its inevitable that schools will now start issuing iPads to students and staff as regularly as they issue text books today.”, says Michael Pike, Chief Software Architect of Life Record Technologies. “We’ve also noticed a lot of healthcare facilities deploying iPads to their staff, and our software allows all of the devices to be managed, observed and secured with ease.”

iWonder Pro Enterprise allows schools and businesses with as little as one iOS device, with up to 10,000 devices to manage them all in one place, including profiles to let certain types of users go to certain types of sites while restricting the others while using any Wifi or cellular network. iWonder Pro Enterprise is the first and only enterprise level surveillance system designed specifically for iOS.

iWonder Pro Enterprise is available now in the Apple App Store starting at $99.99.

More information can be obtained from the iWonder Pro Enterprise website at http://www.iwonderpro.com.

Via EPR Network
More Healthcare press releases

‘The Economic Downturn’ Leads To £1bn Worth Of Angst

Anti-depressant and anxiety drug use has risen 26 per and cost the health service over £1billion since the start of the economic downturn in 2007, according to recent research.

A study by The Co-operative Pharmacy into antidepressant and anxiety drug dispensing across over 150 primary care trusts in England found that in 2010/11 49.8 million items were prescribed, up from 39.5 million items in 2007/08.

However, costs have fallen – down 12 percent from almost £291million in 2007/08, to£258 million in 2010/11.

In 2010/11, the North West had the highest usage of anti-depressants and anxiety medication, with over 8 million items prescribed. It was followed by East of England (5.7m) and Yorkshire and Humber (5.45m) The biggest increase in use over the last four years has been in the East Midlands up 44 percent from 3 to 4.4million items followed by the North East, up 29 percent from 2.7 to 3.5 million items.

Findings by The Co-operative Pharmacy revealed that between 2007/08 and 2010/11 the NHS has spent £1.071billion on prescribed anti-depressants and anxiety drugs. It has also funded a further £1.073billon on drugs for treating psychoses and other related disorders.

Mandeep Mudhar, NHS Business Director, The Co-operative Pharmacy, said: “Our research has shown that the NHS is getting greater value for money but worryingly prescription items have risen at an alarming rate, up 26 per cent in just four years.

“It is clear more people are seeking medical help to treat depression and anxiety. However, there are many more people who do not share their experiences. If people do feel depressed we urge them to seek medical help.”

The research found that citalopram hydrobromide was the most common anti-depressant medication (12.1million items prescribed in 2010/11) followed by amitriptyline HCl (8.8 million prescription items). 5.2 million items of fluoxetine (known commonly as Prozac) were prescribed in 2010/11.

Diazepam was the most widely prescribed drug for anxiety (1.5 million items prescribed in 2010/11).

Emer O’Neill, Chief Executive of Depression Alliance, said: “For some people depression just happens, but for others it is triggered by stressful events, for example losing a job, property or bereavement. These uncertain economic times are linked to an increase in the number of people with the illness.

“However, this is just the tip of the iceberg, as for every person diagnosed with depression there are many more who suffer in silence. Getting an early diagnosis, finding the right support mechanisms and treatment for each individual is crucial to beating the illness. At this time of year, many individuals can feel lonely or isolated but there are a range of support groups available to help with depression. Talking about your feelings is the first step to getting help whether it’s making them known to a friend or family member. It is also important to speak to a healthcare professional such as your GP or pharmacist who can help you to find the best way forward.”

Information is as follows: SHA – 2010/11 anti-depressants/anxiety items – 2007/08
anti-depressants/anxiety items – Items percentage increase/decrease – 2010/11
anti-depressants/anxiety cost – 2007/08 anti-depressants/anxiety cost – Cost
percentage increase/decrease

East Midlands – 4,413,883 – 3,058,017 – +44% – £21,834,708 – £21,334,086 – +2%
East of England – 5,754,445 – 4,550,874 – +26% – £29,602,516 – £33,056,045 – -36%
London 4,555,855 – 3,674,820 – +23% – £25,744,819 – £29,375,164 – -12%
North East – 3,518,868 – 2,725,867 – +29% – £16,660,115 – £19,764,544 – -16%
North West – 8,210,175 – 6,733,905 – +22% – £42,646,532 – £49,872,591 – -15%
South Central – 3,725,478 – 3,006,313 – +24% – £19,260,485 – £22,683,467 – -15%
South East Coast – 3,936,613 – 3,171,974 – +24% – £23,515,527 – £25,174,708 – -7%
South West – 5,439,577 – 4,298,164 – +26% – £26,425,152 – £29,940,081 – -12%
West Midlands – 4,854,135 – 3,890,459 – +25% – £26,751,239 – £29,522,750 – -9%
Yorkshire & Humber – 5,455,370 – 4,445,862 – +23% – £25,919,024 – £30,860,418 – -16%
Total – 49,864,399 – 39,556,255 – +26% – £258,360,117 – £291,583,854 – -12%

Guidance on how to be happy with yourself can be found at The Co-operative’s Magazine online, along with general nutrition advice and wellbeing advice.

Via EPR Network
More Healthcare press releases

Ear Plugs Help You Sleep Soundly Without The Use Of Drugs

All Ear Plugs, an online ear plug retailer, has seen an increase in popularity for sleeping earplugs. Heartech Silentear earplugs have taken the top spot, offering a noise reduction rating of 32 decibels (dB), which eliminates most sounds and allows the wearer to fall asleep peacefully.

Claire Brown, E-Commerce Manager at All Ear Plugs has said that earplugs can be just as, if not more, effective than sleeping pills. “When you suffer from sleepless nights, it’s very easy to turn to tablets in hope that they will make a difference. However, a more cost effective way of ensuring a good night’s sleep can lie in wearing earplugs. Sleeping earplugs like Mack’s Pillow Soft earplugs can eliminate surrounding noises allowing wearers to fall asleep peacefully and quickly.”

It’s easy to fall asleep in silence and that is what sleeping earplugs aim to provide, silence. Eliminating noises such as the sound of ongoing traffic or next door neighbours’ dog can create a peaceful atmosphere. Once that is removed all the thoughts of what you would like to do to the barking dog or the person blasting their horn will turn into peaceful dreams.

The amount of noise you wish to block all lies in the earplugs noise reduction rating. For instance Mack’s Ultra Safe Sound earplugs can eliminate noises up to 32dB. That is the equivalent of a loud conversation and an office environment. It may not seem much, but when you wear these earplugs the sound of city traffic can be reduced from 80 decibels to 48dB.

All Ear Plugs suggests that people should try out a pair of sleeping earplugs before reaching for drugs. Earplugs could offer you the solution you’re after at a fraction of the cost.

Please note if a lack of sleep is affecting your daily life and you feel that it’s a problem, please consult with your GP.

Via EPR Network
More Healthcare press releases

DivanBeds.org.uk Announces New Range of Orthopaedic Beds

DivanBeds.org.uk today announces a fantastic new range of orthopaedic beds available in single, double & king size frames, prices start at £179.

Over time people can develop different types of disorders and ailments that can cause sore muscles and joints and will require some type of special care and comfort. These new and improved orthopaedic beds from DivanBeds.org.uk can help with that issue.

Owner Lee said this about their new orthopaedic beds: “Customers who need that little bit of extra help getting comfortable at night will truly love this range of orthopaedic beds. We also have a sale now on which means you can save up to £140 on selected orthopaedic divan beds.”

DivanBeds.org.uk has been on the cutting edge of contemporary and comfortable bed design for several decades. The typical price of an orthopaedic divan bed packages range between £179 and £369 for an adult double.

DivanBeds.org.uk boasts a wide range of divan beds from round beds to next day divans for under £100. Numerous designs are exclusive to DivanBeds.org.uk, using several years of expertise to source direct from the suppliers. This permits them to cut out the middle man and offer savings as high as 40%.

To view more details on the new collection of orthopaedic beds please visithttp://www.divanbeds.org.uk/orthopaedic-beds/

Via EPR Network
More Healthcare press releases

Get beautiful with The Co-operative Magazine’s beauty videos online

The Co-operative Magazine’s resident fashion and beauty experts have recorded a series of brilliant “how to…” videos, aimed at women who want quick and easy ways to glam up for the festive party season.

The series includes, how to:
• …apply lipstick and lip liner
• …do gorgeous smokey eyes
• …apply professional false eyelashes
• …apply fake tan

It also includes a video guide to curling hair with straighteners for all those women who want to achieve gorgeous, professional-looking wavy locks to go with glamorous, new Christmas party outfits.

These five videos range from 90 seconds and six minutes in length, so it couldn’t be easier or quicker to get the beauty tips and tricks you need to look your best, even if you are short of time. Enjoy step-by-step practical tips on where to apply eyeliner and eye shadow for the perfect smokey look, how to hold hair straighteners to get the easiest curl, why to use a mitt when applying fake tan, and much more.

These beauty videos are perfect for those women who want help with perfecting their look, or who want to try something different for a special occasion. Watch them now online at The Co-operative Magazine, on your desktop PC, mobile phone or tablet and start experimenting with your look!

As well as great video content, The Co-operative Magazine also offers top fashion tips, shopping on a budget, moneysaving and budgeting, how to get fit and much more. Readers will find interesting and engaging topics on everything from travel and leisure to pets, motoring and healthy eating.

The December issue of the online Magazine is now available, and far from being just another Christmas-themed magazine, it gives great alternative meal ideas if you don’t fancy the usual turkey, stuffing and Brussels sprouts, as well as tips on how to have a healthy Christmas and stay out of debt.

Via EPR Network
More Healthcare press releases

Med-Q Introduces Tool to Reduce Medication Errors

When Lee DeMar was running a Phoenix-based nursing agency, he constantly heard his nurses voice their frustration over the fact that many of their older clients were not taking their medications when they should and as a result cycling back to the ER (the nurses worked exclusively at hospitals). Known as medication non-compliance (or non-adherence), it is the failure to take prescription medication on time and in the dosages prescribed.

Medication non-compliance — which has been called America’s “other drug problem” by The New York Times — results in an estimated $290 billion in emergency room visits and other avoidable medical expenses and health crises. These medication errors account for 10 percent of all hospital admissions, and is attributed to at least 125,000 deaths annually, according to the New England Healthcare Institute.

DeMar immediately recognized the urgency of this growing problem and through his company, Med-Q, developed the Med-Q Pillbox, an innovative solution to the challenges of medication non-compliance. The unit retails for $49.95 and is being launched at a special introductory price of $39.95.

Featuring a unique modern design, the Med-Q Pillbox is unlike any pill organizer on the market. It is a self-contained, “all-in-one” electronic weekly organizer, reminder and dispenser. According to DeMar, “The Med-Q Pillbox features a user-friendly design and multipurpose functionality to assist a wide range of individuals taking daily medications and vitamins.”

The Med-Q Pillbox consists of 14 days’ worth of roomy, individualized compartments to accommodate once a day (for 14 days) or twice a day (for 7 days) medication regimens. Each individual compartment is specially fitted with large flip-up tabs for easy opening and can hold the equivalent of up to 30 regular-size aspirins. Additionally, each compartment can be removed from the pillbox base eliminating the potential to spill pills from other compartments that may not be closed securely. An extra large LED makes it easier to program and see the day, time and “next alert.”

Med-Q’s electronic dual reminder system, according to DeMar “is a technology and design breakthrough for individuals and families trying to adhere to daily medication regimens and live a medically-independent life.”

Powered by two AA batteries, the Med-Q Pillbox combines advanced audio and visual alarms, and may be programmed to fit any schedule. The audio alarm, available in one- or two-beep options, cascades in volume and is loud enough to be heard through a nightstand drawer. The visual alarm utilizes LED-Lightbox Technologyâ„¢ to illuminate individual compartments with a flashing light and indicates which pills to take.

The goal of the Med-Q Pillbox is to reduce medication errors. For more information or to purchase the Med-Q Pillbox, please visit www.medqpillbox.com or call 480-648-4977.

Via EPR Network
More Healthcare press releases

Nominate Your Loved One for the ‘Gift of Hearing’ from Estes Audiology

Estes Audiology (www.HearLifeAgain.com), a professional hearing healthcare provider dedicated to improving the lives of the hearing impaired and their families is again giving away three sets of hearing aids during its annual “Gift of Hearing” holiday giveaway. Each year, Estes Audiology donates hearing aids in December to worthy individuals who suffer from hearing loss and lack the financial resources to purchase hearing aids. Estes Audiology is soliciting nominations regarding qualified participants starting today thru December 9, 2011. On December 14th, the recipients of the ‘Gifts of Hearing’ will be notified.

“We are fortunate to live and work in the great communities of New Braunfels, Georgetown and Boerne. During this holiday season, Estes Audiology wants to continue its annual tradition of helping those in need of hearing assistance through our ‘Gift of Hearing’ program, ” said Soriya Estes, Au.D., founder and owner of Estes Audiology. “This annual giveaway is our way of saying thanks to the people of Central Texas. It warms all of our hearts when we hear what an impact our gift has made.”

Jane Whitehouse was a past recipient from the “Gift of Hearing”. When reflecting on the impact of receiving such a gift, she emotionally says, “I cannot put into words what Estes Audiology has done for me. That same year my husband passed away and I was diagnosed with myelodysplastic syndrome, a blood disorder. For years, I had been plagued with hearing loss. With the hearing aids, I could hear again. Words cannot express the gratitude that I feel towards Estes Audiology and its staff for this wonderful gift.” Her daughter-in-law Lisa Whitehouse added, “It was definitely the best Christmas gift I have ever been a part of. Receiving the hearing aids has totally changed her life.”

To be considered as a recipient for ‘the Gift of Hearing’, participants or those who nominate them must write a short essay – 400 words or less – describing how hearing aids would impact them and the lives of the people with whom they interact. Nominations and essays for the ‘Gift of Hearing’ holiday giveaway may be submitted directly to info@estesaudiology.com or may be mailed to Estes Audiology Hearing Center, 1528 Common Street, Suite 5, New Braunfels, Texas 78130. The winners will be selected based on the following criteria: hearing need, financial need, opportunity to impact the recipient’s life, and opportunity to impact the lives of the people with whom they interact.

This is the sixth year that Estes Audiology Hearing Centers has given away sets of hearing aids to deserving individuals. Since the ‘Gift of Hearing’ program’s inception in 2005, Estes Audiology has given away more than 13 pairs of hearing aids to hearing impaired individuals – an in-kind donation worth more than $59,000.

Estes Audiology, a woman-owned professional hearing healthcare provider, was founded by Soriya Estes, Au.D., a well-known Central Texas audiologist and former adjunct professor at the University of Texas-Austin. Estes Audiology currently has offices in New Braunfels, Georgetown, Boerne and San Marcos. Putting its patients first, employing only the most talented and educated staff, using state-of-the-art measurement tools, and providing the most digitally effective hearing solutions and devices, Estes Audiology is the hearing healthcare provider of choice in Central Texas.

To learn more about Estes Audiology and to take its online hearing evaluation, visit HearLifeAgain.com.

Via EPR Network
More Healthcare press releases

Stanley Security Solutions At Healthcare Estates Stand No. F28

Stanley Security Solutions will be exhibiting at this year Healthcare Estates Conference & Exhibition in Manchester Central 1st – 2nd November, for the first time.

Stanley has many years’ experience in supplying the healthcare sector, including hospitals, nursing homes, residential care, secure hospitals and the mental health sector, delivering on-site communication and integrated security solutions for improved patient care and enhanced staff protection. These have included Guys and St Thomas’ Hospitals in London, Northwick Park Hospital in Harrow, University Hospital Birmingham and Gwent Healthcare NHS Trust.

Stanley will be displaying a range of its emergency messaging products for the healthcare sector at the show. When it comes to equipment and personnel safety systems, Stanley has a range of options tried and tested in healthcare premises nationwide, from critical messaging through a choice of paging systems, to lone worker protection services through critical equipment monitoring which immediately alerts you if an important piece of equipment breaks down.

Specific systems being demonstrated by Stanley at the exhibition include Paging and Staff Protection; the new Stanley Pace Pro call confirmation pager which allows calls to be acknowledged and tracked; Stanley’s Pace Wi-Fi mobile providing messaging, alarms, voice and video in one compact handset; Acoustic Monitoring linked to emergency messaging; Nurse Call; and the Stanley DECT digital cordless technology for mobile personnel.

In addition to emergency messaging, Stanley will be promoting its sophisticated security and fire systems at Healthcare Estates Conference & Exhibition. As you would expect from one of the UK’s premier security integrators, Stanley’s security offering includes intruder alarms, audio detection using Sonitrol® Audio Impact technology, video surveillance and access control. Alarm monitoring of all systems is provided using Stanley’s own state-of-the-art ProtectionNet Customer Service Centre, staffed around the clock with trained security professionals ready to handle any emergency.

Fire safety forms a major part of Stanley’s offering, with its regulatory compliant, rapid and reliable fire alarm systems providing early notification to protect life and property.

Stanley is able to provide this comprehensive range of safety and security services in single premises and across multiple locations in a seamless manner. The company’s eDataManager allows easy access to all alarm data from your designated PC, for a completely transparent approach.

To discover more about Stanley Security Solutions’ safety and security services, please go to stand no. F28 or contact Stanley on 01793 692401, or via www.stanley.co.uk.

Via EPR Network
More Healthcare press releases

The Co-operative Magazine Outlines Health Services for Ramadan

The Co-operative Magazine has this week published information on the healthcare services that are available at The Co-operative Pharmacy stores during the Muslim festival of Ramadan.

The Magazine gives its readers the chance to take advantage of the knowledge, expertise and experience of pharmacists at The Co-operative Pharmacy during this important religious festival. Readers are given more information on how to participate safely in Ramadan, Hajj and Umrah, and given details of the dedicated healthcare service for Muslims across the UK.

The article states that specially trained pharmacists will be working at 84 branches of The Co-operative Pharmacy, available to give specific advice and support on all aspects of observing the practices of Ramadan, Hajj and Umrah safely.

Specialist help will include guidance on how to manage regular, orally-administered medication during the period of fasting, as well as advice on how to stop smoking and what vaccinations are necessary for those preparing for Hajj. The Co-operative understands that Ramadan is a good time to beat addiction as those observing the practices of the festival are required to abstain completely from food and resist all temptations during daylight hours.

Business development director at The Co-operative, Mandeep Mudhar, said: “We appreciate the importance of cultural understanding and sensitivity when discussing the implications of healthcare on people’s religious beliefs. But our trained pharmacists are here to help with this and with the preparations leading up to Hajj or Umrah.”

Once Ramadan is over, The Co-operative Pharmacy will focus on giving the meningococcal vaccine, as well as specialist health advice for those making the pilgrimage to Mecca. The Co-operative Pharmacy will be working with Novartis Vaccines and The Muslim Council of Britain to offer meningococcal vaccination (ACWY) packages to Muslim pilgrims.

For more information, read The Co-operative Magazine or find your nearest branch of The Co-operative Pharmacy with the online store finder.

Via EPR Network
More Healthcare press releases

Medelita Offers Top of the Line Lab Coats

Medelita®, maker of breakthrough performance lab coats for both men and women, is changing the way that medical professionals think about their lab coats. Featuring state of the art performance fabric and flattering designs, Medelita offers a long-needed upgrade from the baffling display of flimsy material and ill-fitting silhouettes that have become the subpar standard for white lab coats.

Founded by a clinician, Medelita was born out of personal experience and a true need in the healthcare industry – to offer functional, performance-based lab coats and scrubs of superb quality. Whether they are new to the field or seasoned veterans, medical professionals in all specialties find Medelita lab coats to be perfectly matched to their needs – with ergonomic fit, superb durability, and professional styling.

Medelita professional lab coats are pre-shrunk breathable 100% cotton, resulting in a soft, sophisticated finish. While most white lab coats are made for unisex wear, Medelita and Medelita Men’s lab coats are designed and contoured specifically for either men or women to create a functional, well-fitting garment that remains comfortable throughout the workday. In addition, Medelita offers a variety of styles and features, such as knitted cuffs, modern rounded collars, and deep, durable pockets.

Medelita high-performance lab coats are treated with DuPontâ„¢ Advanced Dual Action Teflon® fabric protector to protect from fluid, soil, and stains, including blood – ideal for medical professionals who are exposed to bodily fluids or other spills. Medelita lab coats also resist stains and washbetter than any other lab coat out there, staying clean and bright white.

Via EPR Network
More Healthcare press releases

Medelita Offers New Caribbean Blue Medical Scrubs

Medelita®, maker of breakthrough performance medical scrubs and lab coats for both men and women, is excited to announce a new color option for their popular medical scrubs. Just in time for summer, Medelita is calling to mind tropical beaches and warm sunny days with the introduction of Caribbean Blue clinician scrubs for women and scrubs for men. Flattering on all skin tones, this modern and professional color is a statement of quality and achievement with name and title embroidery in the clinician scrubs teal option or men’s scrubs cocoa option. Caribbean Blue scrubs will be available for pre-order on July 1st with shipping commencing on July 15th.

The vast majority of scrubs on the market today are boxy, ill-fitting, and un-flattering. These shapeless, unisex uniforms fail to portray the level of

professionalism of those working in healthcare and dentistry. As an Emergency Medicine Physician Assistant, Medelita Founder Lara Manchik, PA-C found herself constantly frustrated by uncomfortable fabrics, horrendous fits, and frumpy silhouettes. By founding Medelita, she set out to create a paradigm shift and offer high quality lab coats and scrubs consistent with the level of prestige and achievement earned by doctors, surgeons, dentists, PAs and other medical professionals.

Unlike most companies, Medelita offers different styles and colors in medical scrubs designed specifically for men or women. With Medelita, medical professionals are no longer forced to wear the bulky and uncomfortable unisex medical scrubs that became prevalent during the last five decades. Featuring ergonomic design features, Medelita scrubs allow professionals a wide range of motion and comfort.

In addition to looking good and feeling comfortable, Medelita medical scrubs are also designed to be both functional and durable. Medelita scrubs are made with a special performance drirelease® fabric with FreshGuard® – making them moisture-wicking, quick drying, and odor-resistant. Drirelease® fabric pulls moisture away from the skin and help to regulate skin temperature, minimizing sweat and discomfort. FreshGuard® is bacteriostatic; it neutralizes and inhibits the growth of bacterial odors – virtually eliminating odor from the uniform.

Via EPR Network
More Healthcare press releases

Enabling microRNA Discoveries – 250th Peer-Reviewed Publication Made Possible By µparaflo Custom Microarray Technology

LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the company’s microarray service for analyzing miRNA expression profiles. These studies, by leading researchers in the field, represent significant steps toward realizing these small regulatory RNA’s potential as biomarkers and therapeutic targets.

MiRNAs have proven to be an extremely important part of the gene expression regulation mechanism of a wide variety of cellular processes. This is evident in the amount of relevant findings by LC Sciences’ customers being translated into published reports and the diverse range of study areas that these publications encompass: cancer research, neuroscience, cardiovascular research, reproductive biology, plant science, microbiology, immunology and stem cell research. LC Sciences’ miRNA profiling service, powered by its µParaflo® custom microarray technology, provides quick, reliable, fully analyzed datasets enabling researchers to immediately move forward with groundbreaking research.

The miRNA field is still nascent, and it is advancing rapidly. The race to discovery has produced a continuous stream of new miRNA sequences as well as routine revisions of inaccurate or incomplete sequences. This fluidity has caused many microarrays with static content to fall away and has fueled reports of the wholesale replacement of microarrays by new methods such as RNA-Seq. But the nimble, customizable format of the µParaflo® array has given it staying power, not only by enabling it to keep current with all known miRNAs, but also by making use of data generated by RNA-Seq. These custom arrays have benefited from RNA-sequencing generating novel content that other arrays are unable to capture and take advantage of.

The 250th study, entitled “Wolbachia uses host microRNAs to manipulate host gene expression and facilitate colonization of the dengue vector Aedes aegypti.” appeared in the May 31st issue of PNAS and was one of a group of articles published recently by LC Sciences’ customers describing microarray expression analysis of miRNAs recently discovered through RNA Sequencing.

Via EPR Network
More Healthcare press releases

Innovators in Health Care Meeting at HealthCamp Florida on July 30, 2011

The inaugural meeting of HealthCamp Florida will be held in Tampa, Florida on July 30, 2011. It will be held on Saturday, July 30 at Kforce in Tampa (1001 E. Palm Ave., Tampa, FL 33605). This is the inaugural event for HealthCamp Florida and the theme is ‘The remarkable innovations that are transforming healthcare.’ The focus will be on technology, policy and process areas and it is expected that these three areas will help to cross-pollinate thoughts, speakers and attendees and inform the discussions.

HealthCamps have been held in a number of other cities, including Boston, Philadelphia, San Francisco and other locations. HealthCamp will be similar to a BarCamp type of unconference but the attendees and speakers will represent a wide variety of people, industries and advocates focused around health care topics. These events have become popular because they involve interesting, high-energy people talking about interesting things.

One of the goals of HealthCamp Florida is to raise awareness of the remarkable innovators and innovations available right here in Florida. The event will bring together interesting people who might otherwise not meet at their own individual industry meetings. This will allow them to share, collaborate, learn and inspire. Some of the extraordinary innovators who are on the cutting edge of health care innovation have committed to attending the event and speaking. They will cover topics ranging from a new non-invasive medical device that provides more accurate predictions of heart risk, to iPhone and iPad apps for health care, to a neural communications device to help the brain communicate with prosthetic limbs, and to a new way to manage patient data and more. The website is www.healthcampflorida.org.

About HealthCamp Florida: HealthCamp Florida is part of the HealthCamp group of events and is designed to look at innovations in HealthCare in general and, focus on people, companies and innovations in Florida.

Via EPR Network
More Healthcare press releases

Medelita Professional Organization Embroidery Logo List Continues to Grow Weekly

Medelita ®, breakthrough performance maker in lab coats and medical scrubs for both men and women, is honored to have a continuously growing list of logo requests received from a variety of professional organizations as well as existing customers.

Logos embroidered on lab coats and medical tops demonstrate pride and accomplishment to colleagues and patients alike. Medelita often refers to embroidery as, “the closest thing to wearing a diploma”. It is because of this significance of wearing both name & title embroidery and the respective logo of a medical or dental specialty, that Medelita has made a commitment to provide the finest quality and craftsmanship as evidenced in every stitch that goes onto a Medelita garment.

Medelita continues to focus on their customer base. As per request by existing customers, the company has added several professional logos to their existing list which include: the American Academy of Cosmetic Surgery (AACS), the American Academy of Dermatology (AAD), the American Association of Endodontists (AAE), the American College of Emergency Physicians (ACEP), the American College of Mohs Surgery (ACMS), the American Academy of Physician Assistants (AAPA), the American College of Physicians (ACP), the American Society of Plastic Surgeons (ASPS), Dental Caduceus, Veterinary Caduceus, American Medical Women’s Association (AMWA), the American Society for Aesthetic Plastic Surgery (ASAPS), the International Society of Aesthetic Plastic Surgery (ISAPS), the society of Dermatology Physician Assistants (SDPA), and Texas Nurse Practitioners (TNP).

Many of the above professional organizations contacted Medelita directly to submit their logos. The organizations recognize a synergy with the quality and professional image that Medelita put forth, and thus selected the company as their preferred vendor for lab coats and scrubs. Medelita is honored to provide such services as well to offer a vast number of professional organization embroidery options.

Via EPR Network
More Healthcare press releases

Medelita Offers a Professional Organization Logo Embroidery Option for Customers

Medelita®, a performance lab coat manufacturer for both men and women, is pleased to provide customers with the option of adding an embroidered Professional Organization Logo when purchasing lab coats and medical scrubs.

Medelita, a leader in online scrubs and lab coats, is honored to have affiliations with numerous professional organizations within the medical and dental industries, including the American Medical Women’s Association and the American Academy of Physician Assistants. Receiving approval to embroider such prestigious logos is indicative of the exceptional quality in craftsmanship and tremendous attention to detail, by Medelita.

Medelita founder, Lara Manchik, PA-C says, “We spend a tremendous amount of time and energy ensuring that every single inch of fabric, trim and finishing detail is perfect. But truly, when a new customer receives their first Medelita lab coat (or clinician scrubs), the very first thing they see is the embroidery. It is their mark of achievement, their symbol of dedication and professionalism that must be displayed with the utmost quality and attention to detail. That is our commitment to our customers and colleagues. We are excited to provide this additional service to our prestigious customer base.”

The embroidered logos are digitized in-house by the expert embroidery team at Medelita, and are stitched directly to the medical uniforms rather than being applied as a typical patch logo. For both custom logos and Professional Organization logos, Medelita embroidery exudes the very highest level of quality and professionalism while making a bold statement to patients and colleagues alike. Medelita often refers to their embroidery services as “the icing on the cake”, allowing medical professionals to display their titles and affiliations with pride and sophistication.

Via EPR Network
More Healthcare press releases

New Report on Fighting Chronic Disease Examines the Importance of Non-Communicable Diseases in Global Health Care

In the first of a series of new reports, a coalition of pharmaceutical industry trade organizations outlines the serious burden that chronic diseases place on patients and global health care systems.“Fighting Chronic Disease: Importance of Non-communicable Diseases” is the first of four reports that look at this growing issue for patients and health care systems around the world.

The report was compiled by the European Federation of the Pharmaceutical Industries and Associations, the International Federation of Pharmaceutical Manufacturers & Associations, the Japan Pharmaceutical Manufacturers Association, and the Pharmaceutical Researchers and Manufacturers Association. Together, these organizations highlight the powerful role that public-private partnerships can play in mitigating the burden of chronic disease. Non-communicable diseases like stroke, heart disease, diabetes, and cancers can often strain global health care resources, and targeting the main risk factors of these conditions can significantly reduce the burden of these diseases worldwide.

Most NCDs are preventable because they are caused by modifiable risk factors, which include poor diet, lack of physical activity and tobacco use. Every year, more than 5 million people die because of direct tobacco use and 2.8 million die from being overweight or obese. High cholesterol accounts for 2.6 million deaths and 7.5 million die because of elevated blood pressure. Individually, chronic disease lowers quality of life for those affected, causes premature deaths and negatively impacts the economic solvency of families, communities and nations. Interventions that focus on better diet, increased physical activity and access to vaccines have been proven to decrease the incidence of chronic disease and improve quality of life.

The pharmaceutical industry has long recognized the economic and social burden of non-communicable diseases (NCDs) and has been working with governments, health care providers, patients groups and other stakeholders as an active solution partner in lessening this burden. The industry promotes and supports health prevention and promotion strategies and patient-centered approaches to managing chronic conditions and their risk factors. At the same time the global biopharmaceutical industry leads the search for new cures and the research and development of new medicines to treat or prevent non-communicable diseases. There are currently thousands of medicines either in clinical trials or awaiting approval to treat NCDs. The great challenge in preventing and controlling NCDs on a global scale is finding patient-centered solutions that reduce the burden on global health care services by promoting individual healthy lifestyles.

The R&D-based pharmaceutical industry works to improve the health and quality of life of all patients, and is committed to continuing partnerships that tackle these complex issues including extensive investment in R&D programs dedicated to the development of new NCD preventative and treatment products. Both prevention and treatment play an important role in addressing the problem of non-communicable diseases.

The full report is available at
http://globalhealthprogress.org/mediacenter/index.php/new-report-examines…

Via EPR Network
More Healthcare press releases

Will the Catholic Church & the U.S. Courts Embrace Advanced Cell Technologies “Embryo-Safe” Technique Using Embryonic Stem Cells?

Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.
• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Via EPR Network
More Healthcare press releases

Global Health Progress Releases Non-Communicable Diseases Partnerships and Programs List

Global Health Progress compiled a list of non-communicable disease treatment programs from around the world, highlighting partnerships to address cancer treatment, diabetes care, epilepsy programs and more. The programs, sponsored by leading companies like Astra Zeneca, Abbott, Novo Nordisk, and Bayer Healthcare, aim to increase awareness of non-communicable diseases in the developing world.

“Our goal in creating this list is to bring awareness to these companies who work so hard at fighting diseases in developing countries,” explains Mark Grayson, Vice President of Communications and Public Affairs at PhRMA and key developer in the Global Health Progress initiative. “Non-communicable diseases are the leading killer in many of these countries, and without the help of these programs they would continue to increase.”

Global Health Progress works with partner groups to encourage and sustain funding for the research and development of healthcare in developing nations. Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

Read the full list of non-communicable disease treatment programs here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/NCD-Health-Partnerships-and-Programs_Worldwide-05-02-11.pdf.

Via EPR Network
More Healthcare press releases

Side by side comparison of Advanced Cell Technology & Geron Corporation

Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements: http://www.sec.gov/Archives/edgar/data/11...

Via EPR Network
More Healthcare press releases

From Universal HIV Testing to HIV Cure

People involved in the fight against HIV/AIDS will gather in Marseille, France, May 23-25, 2012 for an international AIDS Conference under the theme: ‘From Universal HIV Testing to HIV Cure’.

The ISHEID (International Symposium on HIV & Emerging Infectious Diseases) is a major scientific event attracting doctors, biologists, researchers, patients’ representatives and policy makers from all around the world. Its next edition, to be held just more than one year ahead, will focus on recent developments against this pandemic.

Despite major advances in antiretroviral therapy, HIV still infects daily 2,000 new individuals and kills 2 millions each year. Current treatments are life-long with problems of compliance, resistance, toxicity, access, and cost.

‘There are advances both in the area of prevention, testing and potential cure’ told Alain Lafeuillade, a French Doctor involved in the organization of the conference. ‘Our driving force is to draw to the conference the best experts in the world for each program theme’. Antiretroviral treatment as prevention (or pre-exposure prophylaxis) will be debated with the pros and cons. Human rights and access to HIV care will be the focus of en entire session. Current issues in antiretroviral therapy management will be discussed during 2 sessions. Finally, the best American experts in the field of HIV reservoirs and eradication research will present their latest discoveries in the search for a cure.

The international Steering Committee will actively build a program the most exciting possible in the forthcoming months. Meanwhile, interviews of renowned experts are regularly published on the meeting website: http://www.isheid.com/en/committees/interview.html

Via EPR Network
More Healthcare press releases